Allelic loss of 8p sequences in prostatic intraepithelial neoplasia and carcinoma

Urology

Volumn 50, Issue 4, 1997, Pages 643-647

  Häggman, Michael J ^a   Wojno, Kirk J ^a   Pearsall, Carolyn P ^a   Macoska, Jill A ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ALLELE; ARTICLE; CANCER GRADING; CANCER STAGING; CHROMOSOME 8P; DNA SEQUENCE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY;

DNA, NEOPLASM; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS;

EID: 0343416808     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00304-X     Document Type: Article

References (22)

1. McNeal JE, and Bostwick DG: Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol 17: 64-71, 1986.
2. Bostwick DG: Prospective origins of prostate carcinoma. Cancer 78: 330-336, 1996.
3. Bostwick DG: High grade prostatic intraepithelial neoplasia. Cancer Detect Prev Suppl 75: 1823-1836, 1995.
4. Ferguson J, Zincke H, Ellison E, Bergstrahl E, and Bostwick DG: Decrease of prostatic intraepithelial neoplasia following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy. Urology 44: 91-95, 1994.
5. Raviv G, Janssen T, Zlotta AR, Descamps F, Verhest A, and Schulman CS: Prostatic intraepithelial neoplasia: influence of clinical and pathological data on the detection of prostate cancer. J Urol 156: 1050-1054, 1996.
6. Davidson D, Bostwick DG, Qian J, Wollan PC, Oesterling JE, Rudders RA, Siroky M, and Stilmant M: Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies. J Urol 154: 1295-1299, 1995.
7. Shepherd D, Keetch DW, Humphrey PA, Smith DS, and Stahl D: Repeat biopsy strategy in men with isolated prostatic intraepithelial neoplasia on prostate needle biopsy. J Urol 156: 460-463, 1996.
8. McNeal JE, Villers A, Redwine EA, Freiha FS, and Stamey TA: Microcarcinoma in the prostate: its association with duct-acinar dysplasia. Hum Pathol 22: 644-652, 1991.
9. de la Torre M, Haggman M, Brandstedt S, and Busch C: Prostatic intraepithelial neoplasia and invasive carcinoma in total prostatectomy specimens: distribution, volumes and DNA ploidy. Br J Urol 72: 207-213, 1993.
10. Sakr WA, Haas GP, Cassin BF, Pontes JE, and Crissman JD: The frequency of carcinoma and intraepithelial neoplasia of the prostate in young males. J Urol 150: 379-385, 1993.
11. Sakr WA, Grignon DJ, Crissman JD, Heilbrun LK, Cassin BJ, Pontes JE, and Haas GP: High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20 and 69: an autopsy of 249 cases. In Vivo 8: 439-443, 1994.
12. Sakr WA, Macoska JA, Benson P, Grignon DJ, Wolman SR, Pontes JE, and Crissman JD: Allelic loss in locally metastatic, multisampled prostate cancer. Cancer Res 54: 3273-3277, 1994.
13. Emmert-Buck MR, Vocke CD, Pozzatti RO, Duray PH, Jennings SB, Florence CD, Zhuang Z, Bostwick DG, Liotta LA, and Linehan WM: Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res 55: 2959-2962, 1995.
14. Qian J, Bostwick DG, Takahashi S, Borell TJ, Herath JF, Lieber MM, and Jenkins RB: Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res 55: 5408-5414, 1995.
15. Grignon DJ, and Sakr WA: Pathologic staging of prostate carcinoma: what are the issues? Cancer 78: 337-340, 1996.
16. Gleason DF: Histologic grading of prostate cancer: a perspective. Hum Pathol 23: 273-279, 1992.
17. Macoska JA, Benson PD, Turkeri LN, Haas GP, and Sakr W: PCR-based analysis of DNA from autopsied prostate tissue. PCR Meth Appl 2: 354-355, 1993.
18. Macoska JA, Trybus TM, Sakr WA, Wolf MC, Benson PD, Powell IJ, and Pontes JE: Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res 54: 3824-3830, 1994.
19. Rogaev E, Rogaeva E, Lukiw WJ, Vaula G, Liang Y, Hancock R, McLachlan DC, and St George-Hyslop PH: An informative microsatellite repeat polymorphism in the human neurofilament light polypeptide gene (NEFL). Hum Mol Genet 1: 781, 1992.
20. Weber JL, Kwitek AE, May PE, Patterson D, and Drabkin H: Dinucleotide repeat polymorphisms at the D8S85, D8S87 and D8S88 loci. Nucl Acids Res 18: 4038, 1990.
21. Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Matusik RJ, and Rosen JM: Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 92: 3439-3443, 1995.
22. Perez-Stable C, Altman NH, Mehta PP, Deftos LJ, and Roos BA: Prostate cancer progression, metastasis and gene expression in transgenic mice. Cancer Res 57: 900-906, 1997.